Devang Kantesaria

Devang Kantesaria discloses dealings in Rocket Pharmaceuticals, Inc. to SEC (Form 4). We count 3 filings, every one of them for a trade on 23 February 2015.

The open-market record is one-sided, with 1 purchase worth €4.3M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 25 February 2015 came the latest disclosure, an open-market purchase for €4.3M in Rocket Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.